Loader

Publications & Patents

Publications & Patents

Publications & Patents

2007-2018 Publications

2020-04-22 17:10:23

관리자

첨부파일 -

Publications (Citation: >~13,000; H-index: 51, by google scholar as of May 13, 2018)

 

[2018]

 

143. Lee Y, Lee S and Jon S*, “Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-responsive Drug Delivery System for Targeted Cancer Therapy”, Adv. Science. 2018; in press. (IF: 9.034) (Epub April 24)

 

142. Lee S, Lee Y, Kim H, Lee DY and Jon S*, “Bilirubin Nanoparticle-Assisted Delivery of a Small Molecule-Drug Conjugate for Targeted Cancer Therapy”, Biomacromolecules. 2018; in press. (IF: 5.246) (Epub May 4)

 

141. Park S, Jeong JE, Le VS, Seo J, Yu B, Kim DY, Kwon SH, Jon S and Woo HY* and Yang H*, “Enhanced Electron Transfer Mediated by Conjugated Polyelectrolyte and Its Application to Washing-Free DNA Detection”, J. Am. Chem. Soc. 2018; 140(7):2409-2412. (IF: 13.858) (Epub Feb 8)

 

140. Kim Y, Choi M, Mulay SV, Jang M, Kim JY, Lee WH, Jon S and Churchill DG*, “Aqueous red emission probe for the selective fluorescent detection of cysteine by deprotection/cyclization cascade resulting in large Stokes’ shift”, Chemistry 2018; 24(21):5623-5629. (IF: ) (Epub Mar 5)

 

139. Mulay SV, Kim Y, Choi M, Lee DY, Choi J, Lee Y, Jon S and Churchill DG*, “Enhanced Doubly Activated Dual Emission Fluorescent Probes for Selective Imaging of Glutathione or Cysteine in Living Systems”, Anal Chem 2018; 90(4): 2648-2654. (IF: 6.320) (Epub Feb 6)

 

[2017]

 

138. Jeon H, Kim D, Choi M, Kang S, Kim JY, Kim S* and Jon S*, “Targeted cancer therapy using a fusion protein of TNF and a tumor-associated fibronectin-specific aptide”, Mol Pharm 2017; 14(11): 3772-3779. (IF: 4.44) (Nov 6; Epub Oct 11)

 

137. Lee DY, Kim JY, Lee S, Miao W, Kim HS, Min JJ and Jon S*, “Black pigment gallstone-inspired platinum-chelated bilirubin nanoparticles for combined photoacoustic imaging and photothermal therapy of cancers”, Angew. Chem. Int. Ed. 2017; 56(44): 13684-13688. (IF: 11.994) (Oct 23; Epub Sep 4)

 

136. Yoo J, Sanoj Rejinold N, Lee D, Jon S and Kim YC*, “Protease-activatable cell-penetrating peptide processing ROS-triggered phase transition for enhanced cancer therapy”, J. Control. Release 2017; 264, 89-101. (IF: 7.786) (Aug 24)

 

135. Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA and Farokhzad OC*, “Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in LdIr-/- Mice”, Adv. Healthc. Mater. 2017; in press. (IF: 5.11) (Epub Jul 21)

 

134. Kim DE,1 Lee Y,1 Kim M, Lee S, Jon S* and Lee SH*, “Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma”, Biomaterials 2017; 140, 37-44. (IF: 8.402) (Epub Jun 12) (1Equal contribution)

 

133. Keum H, Kim JY, Yu B, Yu SJ, Kim J, Jeon H, Lee DY, Im SG and Jon S*, “Prevention of Bacterial Colonization on Catheters by a One-Step Process Involving an Antibiofouling Polymer in Water”, ACS Appl. Mater. Interfaces 2017; 9(23), 19736-19745. (IF: 7.145) (Epub Jun 1)

 

132. Kim J,1 Kim H,1 Park JH* and Jon S*, “Gold Nanorod-based Photo-PCR System for One-Step, Rapid Detection of Bacteria”, Nanotheranostics 2017; 1(2), 178-185. (IF: ) (May 6) (1Equal contribution)

 

131. Kim D, Jeon H, Ahn S, Choi WI, Kim S* and Jon S*, “An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide”, J. Control. Release 2017; 256: 114-120. (IF: 7.786) (Apr 27)

 

130. Kim MJ, Lee Y, Jon S and Lee DY*, “PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation”, Biomaterials 2017; 133: 242-252. (IF: 8.402) (Jul, Epub Apr 18)

 

129. Kang S, Ahn S, Lee J, Kim JY, Choi M, Gurati V, Kim H, Kim J, Shin EC* and Jon S*, “Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses”, J. Control. Release 2017; 256: 56-67. (IF: 7.786) (Apr 18)

 

128. Kim JY, Lee DY, Kang S, Miao W, Kim H, Lee Y and Jon S*, “Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury”, Biomaterials 2017; 133: 1-10. (IF: 8.402) (Jul, Epub Apr 12)

 

127. Lee Y, Kim S, Kim D and Jon S*, “A histone H-binding-aptide-based apoptosis imaging probe for monitoring tumor responses to cancer therapy”, MedChemComm. 2017: 8, 390. (IF: 2.319) (Epub Jan 05)

 

126. Fang CS, Kim KS, Yu B, Jon S, Kim MS and Yang H*, “Ultrasensitive Electrochemical Detection of miRAN-21 Using a Zinc Finger Protein Specific to DNA-RNA Hybrids”, Anal. Chem. 2017; 89(3): 2024-2031. (IF: 5.886) (Feb 7, Epub Jan 6)

 

125. Saw PE, Yu M, Choi M, Lee E, Jon S* and Farokhzad OC*, “Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy”, Biomaterials 2017; 123: 118-126. (IF: 8.402) (Apr, Epub Jan 31)

 

[2016]

 

124. Mulay SV, Yudhistira T, Choi M, Kim Y, Jang YJ, Jon S and Churchill DG*, “Substituent Effects in BODIPY in Live Cell Imaging”, Chem Asian J. 2016: in press. (IF: 4.592) (Epub 2016 Nov 11)

 

123. Yu SB, Baek J, Choi M, Oh Y, Lee HR, Yu SJ, Lee E, Sohn JW, Im SG* and Jon S*, “Polymer Thin Films with Tunable Acetylcholine-Like Functionality Enable Long-Term Culture of Primary Hippocampal Neurons”, ACS Nano 2016: in press. (IF: 13.334) (Epub 2016 Nov 1)

 

122. Saw PE, Park J, Jon S* and Farokhzad OC*, “A drug-delivery strategy for overcoming drug resistance in breast cancer through targeting of oncofetal fibronectin”, Nanomedicine 2016: in press. (IF: 5.671) (Epub 2016 Oct 18)

 

121. Kim H, Lee Y, Kang S, Choi M, Lee S, Kim S, Gujrati V, Kim J and Jon S* “Self-assembled nanoparticles comprising aptide-SN38 conjugates for used in targeted cancer therapy”, Nanotechnology 2016: 27(48), 48LT01. (IF: 3.573) (Epub 2016 Nov 2)

 

 

120. Miao W, Kim H, Gujrati V, Kim JY, Jeon H, Lee Y, Choi M, Kim J, Lee S, Lee DY, Kang S and Jon S*, “Photo-decomposable Organic Nanoparticles for Combined Tumor Optical Imaging and Multiple Phototherapies”, Theranostics 2016: 6(13), 2367-2379. (IF: 8.854) (2016 Oct 1)

119. Lee Y, Lee S, Lee DY, Yu B, Miao W and Jon S*, “Multi-stimul-responsive bilirubin nanoparticles for anticancer therapy”, Angew. Chem. Int. Ed. 2016: in press.Selected as a Very Important Paper(VIP)

 


118. Mulay SV, Choi M, Jang YJ, Kim Y, Jon S and Churchill DG*. “Enhanced Fluorescence Turn-on Imaging of Hypochlorous Acid in Living Immune and Cancer Cells”, Chemistry - A European Journal 2016; (IF: 3.585) (Epub 2016 May 31)

 

117. Yoo J, Lee D, Gujrati V, Rejinold NS, Lekshmi KM, Uthaman S, Jeong C, Park IK, Jon S and Kim YC*. “Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform”, J. Control. Release 2016: in press. (IF: 7.705) (Epub 2016 May 8)

 

116. Lee Y, Kim H, Kang S, Lee J, Park J and Jon S*, “Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy”, Angew. Chem. Int. Ed. 2016: 55(26), 7460-3. (IF: 11.709) (Jun 20)

 

115. Lee J, Saw PE, Gujrati V, Lee Y, Kim H, Kang S, Choi M, Kim JI, Jon S. “Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.” Theranostics. 2016 Jan 1;6(2):192-203.

 

114. Gujrati V, Lee M, Ko YJ, Lee S, Kim D, Kim H, Kang S, Lee S, Kim J, Jeon H, Kim SC, Jun Y, Jon S. “Bioengineered yeast-derived vacuoles with enhanced tissue-penetrating ability for targeted cancer therapy.” Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):710-5.

 

[2015]

 

113. Sun Y, Kim HS, Saw PE, Jon S, Moon WK. “Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.” Adv Healthc Mater. 2015 Aug 5;4(11):1675-80.

 

 

112. Saw PE, Park J, Lee E, Ahn S, Lee J, Kim H, Kim J, Choi M, Farokhzad OC and Jon S*. “Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes”, Theranostics, 2015; in press. (IF: 7.827) 

111. Choi M, Lee SH, Kim WB, Gujrati V, Kim D, Lee J, Kim JI, Kim H, Saw PE and Jon S*. “Intracellular Delivery of Bioactive Cargos to Hard-to-Transfect Cells Using Carbon Nanosyringe Arrays under an Applied Centrifugal g-Force”, Adv. Healthcare. Mat., 2015; in press. (IF: 4.88)

110. Kim S, Kim D, Lee Y, Jeon H, Lee BH and Jon S*. “Conversion of low-affinity peptides to high-affinity peptide binders using a b‑hairpin scaffold-assisted approach”, ChemBioChem, 2015; 16(1), 43-46. (IF: 3.060) (Jan 2; Epub 2014 Nov 4)

[2014]

109. Kim Y, Choi M, Seo S, Manjare ST, Jon S and Churchill DG*. “A Selective Fluorescent Probe for Cysteine and Its Imaging in Live Cells”, RSC Adv, 2014; 4, 64183-64186. (IF: 3.708) (Epub Nov 20)

108. Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen B, Yu M, Shi J, Tabas I, von Andrian UH, Jon S and Farokhzad OC*. “A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins”, Nano Lett, 2014; 14, 6449-6455. (IF: 12.94) (Oct 21)

107. Park S, Kim Y.-J and Jon S*. “A high-affinity peptide for nicotinic acetylcholine receptor a1 and its potential use in pulmonary drug delivery”, J. Control. Release, 2014; 192, 141-147. (IF: 7.261) (Epub Jul 12; Oct 28).

106. Kim H, Lee E, Lee IH, Lee J, Kim J, Kim S, Lee Y, Kim D, Choi M, Kim YC and Jon S*. “Preparation and Therapeutic Evaluation of Paclitaxel-Conjugated Low Molecular Weight Chitosan Nanoparticles”, Macromol. Res., 2014; 22(8), 805-808. (IF: 1.682) (Aug 31).

105. Yu TK, Shin SA, Kim EH, Kim S, Ryu KS, Cheong H, Ahn HC, Jon S and Suh JY*. “An Unusual Protein-Protein Interaction through Coupled Unfolding and Binding”, Angew. Chem. Int. Ed., 2014; in press. (IF: 13.734) (Jul 1; Epub ).

104. Sun Y, Kim HS, Park J, Li M, Tian L, Choi Y, Choi BI, Jon S* and Moon WK*. “MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles”, Theranostics, 2014; 4(8), 845-857. (IF: 7.806) (Jun 10; Epub Feb 27).

103. Gujrati VB and Jon S*. “Biengineered bacterial outer membrane vesicles: what is their potential in cancer therapy?”, Nanomedicine, 2014; 9(7), 933-935. (IF: 5.26) (May ).

102. Kim D, Lee IH, Kim S, Choi M, Kim H, Ahn S, Saw PE, Jeon H, Lee Y and Jon S*. “A specific STAT3-binding peptide exerts anti-proliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signaling”, Cancer Res., 2014; accepted. (IF: 8.650)

101. Ahn S, Lee IH, Kang S, Kim D, Choi M, Saw PE, Shin EC and Jon S*. “Gold Nanoparticles Displaying Tumor-Associated Self-Antigens as a Potential Vaccine for Effective Cancer Immunotherapy”, Adv. Healthcare. Mat., 2014; accepted.

100. Kim H, Lee Y, Lee IH, Kim S, Kim D, Saw PE, Lee J, Choi M, Kim YC and Jon S*. “Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin”, J. Control. Release, 2014; in press. (IF: 7.633) (Epub Jan 23)

99. Kim C, Yang H, Fukushima Y, Saw PE, Lee J, Park JS, Park I, Jung J, Kataoka H, Lee D, Heo WD, Kim I, Jon S, Adams RH, Nishikawa S, Uemura A and Koh GY*. “Vascular RhoJ is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption”, Cancer Cell, 2014; 25(1), 102-117. (IF: 24.755) (2014 Jan 13).
 
98. Gujrati VB, Kim S, Kim SH, Min JJ, Choy HE, Kim SC and Jon S*. “Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer Therapy”, ACS Nano, 2014; 8(2), 1523-1537. (IF: 12.062) (Feb 25; Epub Jan 15)

97. Jo DH, Kim S, Kim D, Kim HJ, Jon S* and Kim JH*. “VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization”, Biomaterials, 2014; 35(9), 3052-3059. (IF: 7.604) (Epub Jan 1).

96. Lim JM, Bertrand N, Valencia PM, Langer R, Jon S, Farokhzad OC* and Karnik R*. “Parallel Microfluidic Synthesis of Size-Tunable Polymeric Nanoparticles Using 3D Flow Focusing towards In Vivo Study”, Nanomedicine, 2014; 10(2), 401-409. (IF: 6.930) (Epub 2013 Jun 4).

95. Chong K, Ku T, Saw PE, Jon S, Park JH,* Choi C*. “Enhancement of the photocytotoxicity efficiency of sub-12 nm therapeutic polymeric micelles with increased co-localisation in mitochondria”, Chem. Commun., 2013; 49(98), 11476-11478. (IF: 6.378) (Nov 14 2013).

[2013]

94. Lee H, Hong D, Jon S and Choi IS*. “Direct, Noncovalent Coating of a Gold Surface with Polymeric Self-assembled Monolayers”, Bull. Korean Chem. Soc., 2013; 34(12), 3541-3542. (IF: 0.98) (2013).

93. Saw PE, Kim S, Lee IH, Park J, Yu M, Lee J, Kim JI and Jon S*. "Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy". J. Mater. Chem. B, 2013; 1 (37), 4723-4726. (IF: 6.101).

92. Park J,Park S, Kim S, Lee IH, Saw PE, Lee K, Kim YC, Kim YJ, Farokhazad OC,Jeong YY* and Jon S*. "HER2-specific aptide conjugated magneto-nanoclusters for potential breast cancer imaging and therapy". J. Mater. Chem. B, 2013; 1 (36), 4576 - 4583. (IF: 6.101).

91. Ahn S, Lee IH, Lee E, Kim H, Kim YC and Jon S*. "Oral delivery of an anti-diabetic peptide drug via conjugation and complexion with low molecular weight chitosan". J. Controll. Release., 2013; 170(2),226-232.(IF:7.633)(Sep 10 2013; Epub Jun 4 2013).

90. Sung D, Yang S, Park JW and Jon S*. "High-density immobilzation of Antibodies onto Nanobead-coated Cyclic Olefin Copolymer Plastic Surfaces for Application as a Sensitive Immunoassay Chip", Biomed.Microdevices, 2013; 15(4), 691-698. (IF: 2.718) (Aug 2013; Epub Dec 29 2012).

[2012]

89. Kim D and Jon S*. "Gold Nanoparicles in Image-guided Cancer Therapy", Inorganic Chimica Acta, 2012;393,154-164.(IF: 1.846)(Dec 1 2012). Selected as the Top 5 most downloaded articles in 2013.

88. Park J, Kim S, Saw PE, Lee IH, Yu MK, Kim M, Lee K, Kim YC, Jeong YY* and Jon S*. "Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging", J Control. Release, 2012; 163, 111-118.(IF:6.499)(Oct 28 2012). 

87. Lee IH, Kwon HK, An S, Kim D, Kim S, Yu MK, Lee JH, Lee TS, Im SH and Jon S*. "Imageable Antigen-Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo", Angew. Chem. Int. Ed., 2012; 51, 1-7 (IF: 13.46)(Jul 29 2012; Epub 2012) Selected as a Very Important Paper(VIP), Which is granted to top 5%papers by the Journal.

86. Sung D, Park S and Jon S*. "Facile Immobiliztion of Biomolecules onto Vatious Surfaces Using Epoxide-Containing Antibiofouling Polymers", Langmuir. 2012; 28, 4507-4514. (IF: 4.19)(Mar 6 2012; Epub Feb 22 2012)

85. Kim S, Kim D, Jung HH, Lee IH, KIm JI, Suh JY and Jon S*. "Bio-inspired Design and Potential Biomedical Applications of a Novel Class of High Affinity Peptides". Angew. Chem. Int. Ed., 2012; 51, 1890-1894. (IF: 13.46)(Feb 20 2012; Epub Jan 24 2012)(DOI: 10.1002/anie.201107894)

84. Haquet AMJ, Park H, Sung D, Jon S, Choi SY and Kim K*. "An Electrochemically Reduced Graphene Oxide-Based Electrochemical Immunosensing Platform for Ultrasensitive Antigen Detection”, Anal. Chem., 2012; 2012; 84(4), 1871-1878. (IF:5.874 ) (Epub Jan 13 2012) (DOI: 10.1021/ac202562v)

83. Lee HJ, Nguyen YTC, Muthiah M, Vu-Quang H, Namgung R, Kim WJ, Yu MK, Jon S, Lee IK, Jeong YY* and Park IK*. “MR Traceable Delivery of p53 Tumor Suppressor Gene by PEI-Functionalized Superparamagnetic Iron Oixde Nanoparticles”, J. Biomed. Nanotechnol., 2012; 8, 1-11. (IF: 2.626) (Jan 2012)

82. Yu MK, Park J and Jon S*. "Magnetic Nanoparicles and Their Applications in Image-Guided Drug Delivery", Drug Deliv. and Transl. Res., 2012;2,3-21. (Epub Dec 29; 2011)

81. Yu MK, Park J and Jon S*. “Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy”, Theranostics, 2012; 2, 3-44. (Jan 1 2012)

80. Li M, Kim HS, Tian L, Yu MK, Jon S and Moon WK*. “Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors”, Theranostics, 2012; 2, 76-85. (Jan 1 2012)

[2011]

79. Kim SH, Ryu SH, Lee SH, Lee YH, Lee SR, Huh JW, Kim SU, Kim E, Kim S, Jon S, Bishop RE* and Chang KT*. “Instability of toxin A subunit of AB5 toxins in the bacterial periplasm caused by deficiency of their cognate B subunits”, Biochimica et Biophysica Acta, 2011; 1808, 2359-2365. (IF: 4.647) (Oct 2011)

78. Aziz MA, Kim BK, Kim M, Yang SY, Lee HW, Han SW, Kim Y, Jon S and Yang H*. “Immunosensing Microchip Using Fast and Selective Preparation of an Iridium Oxide Nanoparticle-based Pseudoreference Electrode”, Electroanalysis, 2011; 23, 2042-2048. (IF: 2.721) (Sep 2011)

77. Lee SH, Cho B, Yoon S, Jeong H, Jon S, Jung GY, Cho BK and Kim WB*. “Printing of Sub-100-nm Metal Nanodot Arrays by Carbon Nanopost Stamps”, ACS Nano., 2011; 5, 5543-5551. (IF: 9.855) (Jul 2011)

76. Lee IH, An SK, Yu MK, Kwon HK, Im SH and Jon S*. "Targeted Chemoimmunotherapy Using Drug-loaded Aptamer-Dendrimer Bioconjugates", J. Control. Release, 2011; in press (IF:5.95)

76. Lee IH, An SK, Yu MK, Kwon HK, Im SH and Jon S*. “Targeted Chemoimmunotherapy Using Drug-loaded Aptamer-Dendrimer Bioconjugates”, J. Control. Release, 2011; 155, 435-441. (IF: 7.164) (Nov 7)

75. Lee IH, Yu MK, Kim IH, Lee JH, Park TG and Jon S*. “A Duplex Oligonucleotide-Dendrimer Bioconjugate as a Novel Delivery Vehicle for Doxorubicin in in Vivo Cancer Therapy”, J. Control. Release, 2011; 155, 88-95. (IF: 7.164) (Epub Sep 17 2010; Oct 10 2011)

74. Yu MK, Kim D, Lee IH, So JS, Jeong YY and Jon S*. “Image-guided Prostate Cancer Therapy Using an Aptamer-Functionalized TCL-SPION”, Small, 2011; 7, 2241-2249. (IF: 7.33) (Aug 8 2011)

73. Sung D, Shin DH and Jon S*. “Toward Immunoassay Chips: Facile Immobilization of Antibodies on Cyclic Olefin Copolymer Substrates through Pre-Activated Polymer Adlayers”, Biosens. Bioelectron, 2011; 26, 3967-3972. (IF: 5.36) (May 15 2011)

72. Kim D, Yu MK, Lee TS, Park JJ, Jeong YY* and Jon S*. “Amphiphilic Polymer Coated Hybrid Nanoparticles as CT/MRI Dual Contrast Agents”, Nanotechnology, 2011; 22, 155101. (IF: 3.644) (Apr 15 2011)   Top 10% Most Downloaded Articles across all IOP journals! Selected as ‘2011 Highlights’ collection by the editors of of Nanotechnology.

71. Lim SW, Kim HW, Jun HY, Park SH, Yoon KH, Kim HS, Jon S, Yu MK and Juhng SK*. “TCL-SPION-enhanced MRI for the Detection of Lymph Node Metastasis in Murine Experimental Model”, Acad Radiol., 2011: 18, 504-511. (IF: 2.092) (Apr 2011)

70. Kim YS, Park IK*, Kim WJ, Yu MK, Jon S, Pun SH, Jeong MH and Ahn Y*. " SPION Nanoparticles as an Efficient Probe and Carrier of DNA to Umbilical Cord Blood-Derived Mesenchymal Stem Cells", J.Nanosci.Nanotechnol., 2011; 11,1507-1510. (IF:1.435)(Epub)

69. Min K, Jo H, Song K, Cho M, Chun YS, Jon S, Kim WJ and Ban C*. "Dual-Aptamer-Based Delivery Vehicle of Doxorubicin to Both PSMA(+) and PSMA(-) Prostate Cancers", Biomaterials, 2011: 32, 2124-2132. (IF:7.37) (Mar;Epub 2010 Dec13)

[2010]

68. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X and Lee KC. “Preparation and Characterization of Water-soluble Albumin-bound Curcumin Nanoparticles with Improved Antitumor Activity”, Int. J. Pharm, 2011: 403, 285-291. (IF: 2.96) (Jan 17; Epub 2010 Oct 28)

67. Park JC, Yu MK, An GI, Park SI, Oh J, Kim HJ, Kim JH, Wang EK, Hong IH, Ha YS, Kim JY, Lee J, Jeong KS, Chang Y, Welch MJ, Jon S* and Yoo J*. “Facile Preparation of a Hybrid Nanoprobe for Triple-modality Optical/PET/MR Imaging”, Small, 2010; 6, 2863-2868. (IF: 6.17) (Dec 20)

66. Aziz MA, Jo K, Lee JA, Akanda MRH, Sung D, Jon S and Yang H*. “An Amphiphilic Polymer- and Carbon Nanotube-Modified Indium Tin Oxide Electrode for Sensitive Electrochemical DNA Detection with Low Nonspecific Binding”, Electroanalysis 2010; 22, 2615-2619. (IF: 2.63) (Epub Sep 2)

 

 

65. Kim BK, Yang SY, Aziz MA, Jo K, Sung D, Jon S, Woo HY and Yang H*. "Electrochemical Immunosensing Chip Using Selective Surface Modification, Capillary-Driven Microfluidic Control, and Signal Amplification by Redox cycling", Electroanalysis 2010; 22(19),2235-2244. (IF: 2.63) (Epub Jul 22;Oct)

 

64. Lee E, Lee J and Jon S*. “A Novel Approach to Oral Delivery of Insulin by Conjugating with Low Molecular Weight Chitosan”, Bioconjugate Chem, 2010; 21,1720-1723 (IF: 4.35) (Epub Sep 17)

 

63. Yu MK, Park J, Jeong YY, Moon WK and Jon S*. “Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery”, Nanotechnology, 2010; 21(41), 415102. (IF: 3.14) (Oct 15; Epub Sep 17)

 

62. Kim D, Jeong YY and Jon S*. “A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer”, ACS Nano, 2010; 4, 3689-3696. (IF: 7.49) (Jul 27; Epub Jun 15)

 

61. Saw PE, Ko YT and Jon S*. “Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent”, Macromol. Rapid Commun, 2010; 31(13), 1155-1162. (IF: 4.26) (Epub May 20) Selected as a Back Cover Paper


60. Yu MK, Lee S, Chang S* and Jon S*. “NTA•Ni2+-Functionalized Quantum Dots for VAMP2 Labeling in Live Cells”, Bull. Korean. Chem. Soc., 2010; 31(6), 1474-1478. (IF: 1.26) (June 20)

 

59. Namgung R, Singha K, Yu MK, Jon S, Kim YS, Park IK and Kim WJ*. “Hybrid superparamagnetic iron oxide nanoparticle-branched polyethyleneimine magnetoplexes for gene transfection of vascular endothelial cells”, Biomaterials, 2010; 31(14), 4204-4213. (IF: 7.37) (May; Epub Feb 18)

[2009]

 

58. Das J, Kim H, Jo K, Park KH, Jon S, Lee K and Yang H*. “Fast Catalytic and Electrocatalytic Oxidation of Sodium Borohydride on Palladium Nanoparticles and Its Application to Ultrasensitive DNA Detection”, Chem. Commun, 2009; 6394-6396. (IF: 5.34) (Nov 14; Epub Oct 1)

 

57. Sung D, Park S and Jon S*. “Facile Method for Selective Immobilization of Biomolecules on Plastic Surfaces”, Langmuir, 2009; 25, 11289-11294. (IF: 4.10) (Oct 6; Epub Sep 09)

 

56. Lee E, Kim H, Lee IH and Jon S*. “In Vivo Antitumor Effects of Chitosan-Conjugated Docetaxel after Oral Administration”, J. Control. Release., 2009; 140, 79-85. (IF: 5.69) (Dec 3; Epub Aug 24) Selected as a Cover Paper.


55. Hue J, Lee B, Kang B, Kim J, Chai H, Jo K, Yu MK, Jon S, Jeong J, Kim J and Han B*. “In Vivo Kinetics of Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles in Rats”, J. Am. Assoc. Lab. Animal Sci., 2009; 48, 621-622. (IF: 0.95) (Sep)

 

54. Kim J, Hue J, Kang B, Kim J, Chai H, Lee B, Jeong J, Jon S, Han B, Yu MK and Jo K*. “In Vivo Distribution of Cy5.5-Conjugated Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles in Mice”, J. Am. Assoc. Lab. Animal Sci., 2009; 48, 624. (IF: 0.95) (Sep)

 

53. Park J, Yu MK, Jeong YY, Kim JW, Lee K, Phan VN and Jon S*. “Antibiofouling, amphiphilic polymer-coated superparamagnetic iron oxide nanoparticles: synthesis, characterization, and use in cancer imaging in vivo”, J. Mater. Chem., 2009; 19, 6412-6417. (IF: 4.65) (Epub Jun 10)

 

52. Kim D, Kim JW, Jeong YY* and Jon S*. “Antibiofouling Polymer Coated Gold@Iron Oxide Nanoparticle as a Dual Contrast Agent for CT and MRI”, Bull. Korean. Chem. Soc., 2009; 30, 1855-1857. (IF: 1.26) (Jul ?)

 

51. Cho WS, Cho M, Kim SR, Choi M, Lee JY, Han BS, Park S, Yu MK, Jon S, Jeong J*. “Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging”, Toxicol Appl Pharm., 2009; 239, 106-115. (IF: 3.36) (Aug 15; Epub Jun 9).

 

50. Kim S, Park JW, Kim D, Kim D and Jon S*. “Bioinspired Colorimetric Detection of Calcium Ion in Serum Using Calsequestrin-Functionalized Gold Nanoparticles”, Angew. Chem. Int. Ed., 2009; 48, 4138-4141. (IF: 10.88) (Epub May 7 ). Selected as a Hot Paper.


49. Park S, Kim YS, Kim WB* and Jon S*. “Carbon Nanosyringe Array as a Platform for Intracellular Delivery”, Nano Lett., 2009; 9(4), 1325-1329. (IF: 10.37) (Apr; Epub Mar 2) Highlighted in “Nanowerk Magazine” and “Nature Asia Materials”.


48. Bagolkot V, Lee IH, Yu MK, Lee E, Park S, Lee JH and Jon S*. “A Combined Chemoimmunotherapy Approach Using a Plasmid-Doxorubicin Complex”, Mol. Pharm., 2009; 6(3), 1019-1028. (IF: 4.57) (Epub Apr 1)

 

47. Das J, Huh CH, Kwon K, Park S, Jon S and Yang H*. “Comparison of the Nonspecific Binding of DNA-Conjugated Gold Nanoparticles between Polymeric and Monomeric Self-Assembled Monolayers”, Langmuir, 2009; 25(1), 235-241. (IF: 4.10) (Dec 31; Epub Nov 25)

 

46. Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY and Jon S*. “Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel”, J. Med. Chem, 2008; 51(20), 6442-6449. (IF: 4.95) (Oct 23; Epub Oct 1)

 

[2008]

45. Wang AZ, Bagalkot V, Vasilliou C, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima M, Langer R, Kantoff PW, Bander NH, Jon S* and Farokhzad OC*. “Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy”, ChemMedChem, 2008; 3(9), 1311-1315. (IF: 2.85) (Sep 5; Epub Jul 9)

 

44. Yu MK, Jeong YY, Park JH, Park SJ, Kim JW, Min JJ, Kim KW and Jon S*. “Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo”, Angew. Chem. Int. Ed., 2008; 47, 5362-5365. (IF: 10.03) (July 7; Epub Jun 12)

 

43. Kim EJ, Shin HY, Park S, Sung D, Jon S*, Sampathkumar SG, Yarema KJ, Choi SY, and Kim K*. “Electrochemically active, anti-biofouling polymer adlayers on indium-tin-oxide electrodes”, Chem. Commun. 2008; 3543-3545. (IF: 5.14) (Aug 14; Epub May 30)

 

42. Park S, Yang HS, Kim D, Jo K and Jon S*. “Rational design of amphiphilic polymers to make carbon nanotubes water-dispersible, anti-biofouling, and functionalizable”, Chem. Commun. 2008; 2876-2878. (IF: 5.14) (Jul 7; Epub Apr 17) Highlighted in “Chemical Science” and in “Chemistry World” (the RSC’s monthly magazine).


41. Horvath G, Premkumar T, Boztas A, Lee E, Jon S and Geckeler KE. “Supramolecular Nanoencapsulation as a Tool: Solubilization of the Anticancer Drug trans-Dichloro(dipyridine)platinum(II) by Complexation with beta-Cyclodextrin”, Mol. Pharm. 2008; 5, 358-363. (IF: 11.5) (Epub Feb 19)

 

40. Lee BS, Park S, Lee KB, Jon S* and Choi IS*. “Selective immobilization of biomolecules onto an activated polymeric adlayer”, Biointerphases 2007; 2, 136-142. (Nov 8) Top 20 Most Downloaded Articles during March 2008.

 

[2007]

39. Lee J, Kwon OS, Shin K*, Song JM, Kim JS, Seo YS, Tae G and Jon S. “Surface modification for polystyrene colloidal particles with controlled charge densities”, J. Nanosci. Nanotechnol. 2007; 7, 3995-3999. (IF: 2.1) (Nov; Epub Oct 16)

 

 

38. Jung J, Lee IH, Lee E, Park JH and Jon S*. “pH-Sensitive Polymer Nanospheres for Use as a Potential Drug Delivery Vehicle”, Biomacromolecules, 2007; 8, 3401-3407. (IF: 3.66) (Epub Oct 16)

 

37. Park S, Lee KB, Choi IS and Jon S*. “Dual Functional, Polymeric Self-Assembled Monolayers as a Facile Platform for Construction of Patterns of Biomolecules”, Langmuir 2007; 23, 10902-10905. (IF: 3.90) (Oct 23; Epub Sep 28)

 

36. Lee H, Yu MK, Park S, Moon S, Min JJ, Jeong YY* and Jon S*. “Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles: Synthesis and Application as a Dual Imaging Probe for Cancer in Vivo”, J. Am. Chem. Soc., 2007; 129, 12739-12745. (IF: 7.70) (Oct 24; Epub Sep 25) Highlighted in “Biophotonics International” (December, 2007).


35. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S*, Kantoff PW, Langer R and Farokhzad OC*. “Quantum Dot-Aptamer Conjugates for Synchronous Cancer Imaging, Therapy and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer”, Nano Lett. 2007; 7, 3065-3070. (IF: 9.96) (Oct; Epub Sep 14) Highlighted in “Biophotonics International” (December, 2007)


34. Cho WK, Park S, Jon S* and Choi IS*. “Water-Repellent Coating: Formation of Polymeric Self-Assembled Monolayers on Nanostructured Surfaces”, Nanotechnology 2007; 18, 395602 (7ps). (IF: 3.04) (Epub Sep 4)

 

33. Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer R and Farokhzad OC*. “Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates”, ChemMedChem 2007; 2, 1268-1271. (IF: 2.85) (Sep; Epub Jun 28)

 

32. Kim D, Park S, Lee JH, Jeong YY* and Jon S*. “Antibiofouling Polymer-Coated Gold Nanoparticles as a Contrast Agent for in Vivo X-ray Computed Tomography Imaging”, J. Am. Chem. Soc., 2007; 129, 7661-7665. (IF: 7.70) (Jun 20; Epub May 27)

 

31. Aziz MA, Park S, Jon S and Yang H*. “Amperometric immunosensing using an indium tin oxide electrode modified with multi-walled carbon nanotube and poly(ethylene glycol)-silane copolymer”, Chem. Commun. 2007; 2610-2612. (IF: 4.52) (Jul 7; Epub Apr 3)

 

30. Choi J, Kim J, Kim K,* Yang ST, Kim JI and Jon S*. “A Rationally Designed Macrocyclic Cavitand That Kills Bacteria with High Efficacy and Good Selectivity”, Chem. Commun., 2007; 1151-1153. (IF: 4.52)

 

29. Bagolkot V, Farokhzad OC,* Langer R and Jon S*. “An Aptamer-Doxorubicin Physical Conjugate as A Novel Targeted Drug Delivery Platform”, Angew. Chem. Int. Ed., 2006; 45, 8149-8152.(IF: 9.60)

 

28. Park S, Chi YS, Choi IS, Seong J* and Jon S*. “A Facile Method for Construction of Antifouling Surfaces by Self-Assembled Polymeric Monolayers of PEG-Silane Copolymers Formed in Aqueous Medium”, J. Nanosci. Nanotechnol. 2006, 6 (11), 3507-3511.

 

다음글
2019-Present Publications
이전글
Patents, Books, and Invited Lectures
삭제 수정 목록